Device Cervical

Infinity Occipitocervical Upper Thoracic System

Payments companies reported to CMS as associated with Infinity Occipitocervical Upper Thoracic System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$735Kassociated payments (2023-2025)
685clinicians with associated payments
1company reporting

By year

2023 $121K
2024 $334K
2025 $280K

Payments reported as associated with Infinity Occipitocervical Upper Thoracic System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurological Surgery $481K
Orthopaedic Surgery $151K
Orthopaedic Surgery of The Spine $88K
Physician Assistant $2,994
Colon & Rectal Surgery $2,273
Surgical $1,298

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Infinity Occipitocervical Upper Thoracic System

These are the largest totals companies reported as associated with Infinity Occipitocervical Upper Thoracic System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Christopher Martin Minneapolis, MN Orthopaedic Surgery $77,704.62
Deb Bhowmick Chapel Hill, NC Neurological Surgery $47,245.66
Justin Smith Charlottesville, VA Neurological Surgery $41,636.34
Domagoj Coric Charlotte, NC Neurological Surgery $36,938.76
Charles Crawford Louisville, KY Orthopaedic Surgery of The Spine $36,638.31
Martin Pham Los Angeles, CA Neurological Surgery $36,199.99
Tiffany Perry Los Angeles, CA Neurological Surgery $34,927.88
Joshua Loewenstein Chapel Hill, NC Neurological Surgery $33,838.34
Lawrence Lenke New York, NY Orthopaedic Surgery $32,991.14
Patrick Sugrue Park Ridge, IL Neurological Surgery $30,014.49

Prescribed Infinity Occipitocervical Upper Thoracic System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.